LoadingLoadingLoading37 funds hold it.Insiders net selling.
Net selling: insiders sold $924K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 5, 2026
Financial period
Q3 2026
Earnings per share
$7.51 expected
Revenue
$72.45B expected
Estimates as of Nov 9, 2026
EPS expected
$7.22 to $7.63
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 5, 2026 | $7.98est. $7.51 | +6.30%beat | $73.68Best. $72.45B+1.70% | +5.6%from $69.75B |
| Jun 30, 2026Reported Jul 30, 2026 | $7.78est. $7.60 | +2.37%beat | $71.67BCompany release | +6.7%from $67.18B |
| Mar 31, 2026Reported Apr 30, 2026 | $7.79est. $7.61 | +2.41%beat | $68.49BSEC filing | +4.6%from $65.50B |
| Dec 31, 2025Reported Feb 5, 2026 | $8.08est. $7.88 | +2.50%beat | $72.47BAlpha Vantage | +10.4%from $65.65B |
| Sep 30, 2025Reported Oct 30, 2025 | $7.83est. $7.64 | +2.49%beat | $69.75BSEC filing | +9.5%from $63.69B |
| Jun 30, 2025Reported Jul 31, 2025 | $7.20est. $7.15 | +0.70%in line | $67.18BSEC filing | +11.0%from $60.52B |
| Mar 31, 2025Reported May 2, 2025 | $6.74est. $6.35 | +6.14%beat | $65.50BSEC filing | +14.4%from $57.26B |
| Dec 31, 2024Reported Jan 30, 2025 | $6.64est. $7.82 | -15.09%miss | $65.65BAlpha Vantage | +28.4%from $51.11B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $69.75B | $72.47B | $68.49B | $71.67B |
| Cost of what it sold | $63.81B | $66.92B | $62.02B | $56.70B |
| Gross profit | $5.94B | $5.55B | $6.47B | $14.96B |
| What it spent | ||||
| Sales and admin | $3.36B | $3.41B | $3.72B | $3.47B |
| Other operating costs | — | — | $390.0M | $8.82B |
| Total operating expenses | $3.36B | $3.41B | $4.11B | $12.29B |
| What was left | ||||
| Operating profit | $2.58B | $2.15B | $2.36B | $2.68B |
| Interest on debt | $347.0M | $335.0M | $357.0M | $356.0M |
| Profit before tax | $2.29B | $1.63B | $2.27B | $2.26B |
| Tax | $322.0M | $395.0M | $409.0M | $382.0M |
| Net profit | $1.87B | $1.23B | $1.65B | $1.66B |
| EBITDA | $3.34B | $2.69B | $3.28B | $3.27B |
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Why Is Centene (CNC) Gaining Election Driven Momentum After The U.S. Vote?
NeutralNov 7Cigna’s third-quarter earnings show a drop in income from its pharmacy benefit business
Leans bearishNov 6Cigna Invests $1.5M in Regional Healthcare Access
BullishNov 6Cigna Invests $1.5M in Regional Healthcare Access
BullishNov 6How Investors May Respond To Cigna Stock Earnings Beat
NeutralNov 6FocalTherics Q3 Earnings Call Highlights
Leans bullishNov 6Cigna Lifts 2026 Profit Target to $30.60 a Share as Specialty Pharmacy Delivers
BullishNov 6Cigna boosts 2026 outlook as insurance, specialty pharmacy profits climb
BullishNov 531 macro signals shaping CI right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
